Sex Disparities in Cardiovascular Disease

Madeline K Mahowald1, Khadeeja Esmail1, Fatima M Ezzeddine2

  • 1University of Florida College of Medicine, Jacksonville, Florida, US.

Insights

Cardiovascular disease (CVD) is the top cause of death for women, often underdiagnosed and undertreated. This review highlights disparities in CVD risk factors, management, and outcomes, proposing strategies for improvement.

Area of Science:

  • Cardiology
  • Women's Health
  • Health Disparities

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in women globally.
  • Significant underdiagnosis, undertreatment, and worse outcomes for CVD are observed in women compared to men.
  • Disparities permeate all levels of cardiovascular science and practice, affecting women disproportionately.

Purpose of the Study:

  • To review and highlight the differences in cardiovascular risk factors and management disparities in women.
  • To examine disparities in outcomes for key cardiovascular conditions including ischemic heart disease, heart failure, aortic stenosis, and atrial fibrillation.
  • To assess female representation in clinical trials, leadership roles, and academic institutions within cardiovascular medicine.

Main Methods:

  • Literature review and synthesis of existing research on sex differences in cardiovascular disease.
  • Analysis of data concerning disparities in diagnosis, treatment, and patient outcomes.
  • Examination of female participation and leadership in cardiovascular research and professional societies.

Main Results:

  • Women exhibit distinct cardiovascular risk factor profiles and experience disparities in the management of major cardiovascular diseases.
  • Outcomes for ischemic heart disease, heart failure, aortic stenosis, and atrial fibrillation are often worse in women due to these disparities.
  • Underrepresentation of women in clinical trials and leadership positions exacerbates these inequities.

Conclusions:

  • Addressing sex-based disparities in cardiovascular disease is critical for improving women's health outcomes.
  • Implementing targeted strategies and increasing female representation are essential to overcome existing inequities in cardiovascular care and research.
  • Successful programs demonstrate the feasibility of mitigating these disparities through focused interventions and policy changes.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
328
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
145
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
237
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K